7/30/2010

Calibra Medical has received 510(k) clearance from the FDA for Finesse, an insulin patch-pen that can be used for up to three days with Novo Nordisk's insulin aspart. The device was previously approved for use with Eli Lilly & Co.'s insulin lispro.

Related Summaries